Vertex Pharmaceuticals Inc VRTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:23 PM EDT
215.94UNCH (UNCH)
Volume
124,952
Close
215.94quote price arrow up+2.34 (+1.10%)
Volume
1,502,530
52 week range
202.56 - 306.08

...

Loading . . .
  • Open214.61
  • Day High218.70
  • Day Low214.46
  • Prev Close213.60
  • 52 Week High306.08
  • 52 Week High Date07/07/20
  • 52 Week Low202.56
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap55.89B
  • Shares Out258.82M
  • 10 Day Average Volume1.72M
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • YTD % Change-8.63

KEY STATS

  • Open214.61
  • Day High218.70
  • Day Low214.46
  • Prev Close213.60
  • 52 Week High306.08
  • 52 Week High Date07/07/20
  • 52 Week Low202.56
  • 52 Week Low Date11/02/20
  • Market Cap55.89B
  • Shares Out258.82M
  • 10 Day Average Volume1.72M
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • YTD % Change-8.63

RATIOS/PROFITABILITY

  • EPS (TTM)10.30
  • P/E (TTM)20.96
  • Fwd P/E (NTM)19.25
  • EBITDA (MRQ)2.979B
  • ROE (MRQ)36.71%
  • Revenue (MRQ)6.206B
  • Gross Margin (MRQ)88.14%
  • Net Margin (MRQ)43.70%
  • Debt To Equity (MRQ)6.69%

EVENTS

  • Earnings Date04/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:0303:03
We're really excited that these genomics companies, says Ark's Simon Barnett

Profile

MORE
Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are ORKAMBI and KALYDECO. ORKAMBI (lumacaftor in combination with ivacaftor) is approved as a treatment for patients having...
Jeffrey Leiden M.D. Ph.D.
Chairman
Reshma Kewalramani M.D.
President
Charles Wagner Jr.
Chief Financial Officer
Michael Parini J.D.
Executive Vice President
Carmen Bozic
Executive Vice President
Address
50 Northern Ave
Boston, MA
02210-1862
United States

Top Peers

SYMBOLLASTCHG%CHG
TAK
Takeda Pharmaceutical Co Ltd
17.00-0.15-0.87%
ZTS
Zoetis Inc
163.47+0.96+0.59%
CTLT
Catalent Inc
109.04-0.34-0.31%
HZNP
Horizon Therapeutics PLC
91.62+1.83+2.04%
ELAN
Elanco Animal Health Inc
29.39-0.01-0.03%